India to Canada: Digoxin Export Trade Route

The India to Canada Digoxin corridor is one of India's established pharmaceutical export routes, with 8 shipments documented worth a combined $95.5K USD. The route is dominated by ACME GENERICS LLP, which alone accounts for roughly 76% of all export value, reflecting the consolidated nature of India's digoxin manufacturing sector.

Across 3 active suppliers, the average shipment value stands at $11.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 73% of all shipments, consistent with digoxin's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 24 days port-to-port. The route has recorded an annual growth rate of 20.6%, placing it at rank #18 among India's top digoxin export destinations globally.

On the import side, key buyers of Indian digoxin in Canada include Jamp Pharma Corporation, JAMP PHARMA CORPORATION, JAMP PHARMA CORP. and 1 others. Jamp Pharma Corporation is the single largest importer with 2 shipments valued at $51.4K USD.

India's digoxin exports to Canada are driven primarily by a handful of large-scale manufacturers. ACME GENERICS LLP with 4 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in Canada benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — ACME GENERICS LLP, ACME GENERICS PRIVATE LIMITED , ACME GENERICS PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $11.9K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as digoxin 0.0625 mg tablets, 1 x 100t, b. no.eg24dgx001, mfg dt.apr-24, exp dt.mar-26 and jamp digoxin 0.125 mg tablets batch no.eg23dgy001 manufacturing dt.aug-23 exp. dt.july-25 6000x1x100t, suggesting that buyers in Canada tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, Jamp Pharma Corporation is the largest importer with 2 shipments worth $51.4K USD — representing 54% of all digoxin imports from India on this route.